BCG administration promotes the long-term protection afforded by a single-dose intranasal adenovirus-based SARS-CoV-2 vaccine

Recent publications have explored intranasal (i.n.) adenovirus-based (Ad) vaccines as an effective strategy for SARS-CoV-2 in pre-clinical models. However, the effects of prior immunizations and infections have yet to be considered. Here, we investigate the immunomodulatory effects of Mycobacterium...

Descripción completa

Detalles Bibliográficos
Autores principales: Perera, Dilhan J., Domenech, Pilar, Babuadze, George Giorgi, Naghibosadat, Maedeh, Alvarez, Fernando, Koger-Pease, Cal, Labrie, Lydia, Stuible, Matthew, Durocher, Yves, Piccirillo, Ciriaco A., Lametti, André, Fiset, Pierre Olivier, Elahi, Seyyed Mehdy, Kobinger, Gary P., Gilbert, Rénald, Olivier, Martin, Kozak, Robert, Reed, Michael B., Ndao, Momar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475483/
https://www.ncbi.nlm.nih.gov/pubmed/37670783
http://dx.doi.org/10.1016/j.isci.2023.107612

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10475483/
https://www.ncbi.nlm.nih.gov/pubmed/37670783
http://dx.doi.org/10.1016/j.isci.2023.107612

Ejemplares similares